Wearables and advanced algorithms are expanding FemTech beyond fertility tracking, but scientific validation, regulation, and privacy remain essential for clinical adoption.

Those who use hormonal birth control, particularly those who switch methods multiple times, are far more likely to take semaglutide later in life.

People with moderate-to-severe plaque psoriasis in Europe could soon gain access to the first oral medicine targeting the interleukin (IL)-23 pathway, after the European Medicines Agency’s (EMA) ...

European regulators recommended Lynavoy, a novel oral ileal bile acid transporter inhibitor, for primary biliary cholangitis patients with cholestatic pruritus.

Spouses of individuals with dementia have a significantly higher risk of developing dementia, new research shows.

Followed over decades, a cohort of children with faster BMI accumulation was more likely to develop clusters of metabolic diseases in adulthood, with the highest risk found in men.